Epicardial adipose tissue provides incremental value in predicting major adverse cardiac events in systemic sclerosis patients without pulmonary arterial hypertension beyond traditional risk factors

High EFV levels are independently associated with MACE risk among SSc patients, with poorer prognostic outcomes being evident among patients with SSc even if they were unaffected by PAH. The introduction of EFV offers incremental utility over traditional risk factors alone for the prediction of MACE incidence.